These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11846222)

  • 1. Skin dendritic cells in murine cutaneous leishmaniasis.
    Udey MC; von Stebut E; Mendez S; Sacks DL; Belkaid Y
    Immunobiology; 2001 Dec; 204(5):590-4. PubMed ID: 11846222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.
    Moll H
    Behring Inst Mitt; 1997 Mar; (99):73-8. PubMed ID: 9303204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis.
    Will A; Blank C; Röllinghoff M; Moll H
    Eur J Immunol; 1992 Jun; 22(6):1341-7. PubMed ID: 1601029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes.
    Brewig N; Kissenpfennig A; Malissen B; Veit A; Bickert T; Fleischer B; Mostböck S; Ritter U
    J Immunol; 2009 Jan; 182(2):774-83. PubMed ID: 19124720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major.
    Gaafar A; Veress B; Permin H; Kharazmi A; Theander TG; el Hassan AM
    Clin Immunol; 1999 Jun; 91(3):314-20. PubMed ID: 10370377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
    Moll H; Fuchs H; Blank C; Röllinghoff M
    Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy.
    von Stebut E
    Exp Dermatol; 2007 Apr; 16(4):340-6. PubMed ID: 17359341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.
    Silveira FT; Lainson R; Gomes CM; Laurenti MD; Corbett CE
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1075-80. PubMed ID: 18602127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages.
    Stefani MM; Müller I; Louis JA
    Eur J Immunol; 1994 Mar; 24(3):746-52. PubMed ID: 7510243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 cytotoxic T cells in cutaneous leishmaniasis.
    Ruiz JH; Becker I
    Parasite Immunol; 2007 Dec; 29(12):671-8. PubMed ID: 18042173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin mast cells control T cell-dependent host defense in Leishmania major infections.
    Maurer M; Lopez Kostka S; Siebenhaar F; Moelle K; Metz M; Knop J; von Stebut E
    FASEB J; 2006 Dec; 20(14):2460-7. PubMed ID: 17142795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal inoculation of Leishmania-antigen by gold bombardment results in a chronic form of leishmaniasis.
    Weiss R; Scheiblhofer S; Thalhamer J; Bickert T; Richardt U; Fleischer B; Ritter U
    Vaccine; 2007 Jan; 25(1):25-33. PubMed ID: 17064826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis.
    Fritzsche C; Schleicher U; Bogdan C
    Immunobiology; 2010; 215(9-10):826-32. PubMed ID: 20576313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology. Neutrophil soldiers or Trojan Horses?
    John B; Hunter CA
    Science; 2008 Aug; 321(5891):917-8. PubMed ID: 18703727
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the in situ inflammatory reaction an important tool to understand the cellular immune response in American tegumentary leishmaniasis?
    Morgado FN; Schubach A; Rosalino CM; Quintella LP; Santos G; Salgueiro M; Conceição-Silva F
    Br J Dermatol; 2008 Jan; 158(1):50-8. PubMed ID: 17944980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming of Leishmania-reactive CD8+ T cells in vivo does not require LMP7-containing immunoproteasomes.
    Brosch S; Tenzer S; Akkad N; Lorenz B; Schild H; von Stebut E
    J Invest Dermatol; 2012 Apr; 132(4):1302-5. PubMed ID: 22277939
    [No Abstract]   [Full Text] [Related]  

  • 20. Human primary dendritic cell subsets differ in their IL-12 release in response to Leishmania major infection.
    Zahn S; Kirschsiefen P; Jonuleit H; Steinbrink K; Von Stebut E
    Exp Dermatol; 2010 Oct; 19(10):924-6. PubMed ID: 20707811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.